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Diarrheal disease is a leading cause of child mortality worldwide. Bacteria 
belonging to the genus Aeromonas have been debated as one of the causative 
agents of gastroenteritis. During the 2010 Haitian cholera outbreak, fecal samples 
were gathered from 81 patients suffering symptoms of diarrhea, vomiting, and 
abdominal pain. These isolates were investigated for Vibrio cholerae and 
Aeromonas species. Bacteria from these samples were isolated and characterized 
using polymerase chain reaction (PCR) and biochemical testing. Identification of 
Aeromonas was performed to species level using multi-locus sequence typing 
(MLST) analysis. Aeromonas caviae was identified in 17 fecal samples (21%). 
Putative virulence factors in each strain were determined using additional PCR 
and biochemical analysis. Both V. cholerae and A. caviae were confirmed in 
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Chapter 1 Literature Review 
Agents and Consequences of Diarrheal Disease 
 Diarrheal diseases remain a major health concern worldwide and account 
for approximately 17% of all deaths among children five years and younger. This 
rate is higher than that of AIDS, malaria, and measles combined [1]. Diarrhea is 
typically the symptom of an infection of the intestinal tract caused by a variety of 
bacterial, viral, and/or parasitic enteric pathogens. These organisms are spread 
from person to person through the fecal-oral route, typically by consumption of 
food or water naturally contaminated or transmission of a fecal pathogen from a 
carrier of the disease [2, 3].  
 Bacterial agents include Vibrio cholerae, Shigella spp. and Salmonella 
spp., as well as enteropathogenic Escherichia coli (EPEC) and enterotoxigenic E. 
coli (ETEC) which are globally the most common bacterial pathogenic agents of 
diarrheal disease [4]. Two of the most frequently reported viral diarrheal 
pathogens are rotavirus and norovirus [5]. It is estimated that norovirus is 
responsible for 10% to 38% of global diarrhea-related inpatient and outpatient 
visits among children under 5 years of age [6]. Less commonly reported diarrheal 
pathogens include eukaryotic parasitic organisms, e.g., Giardia intestinalis, 
Cryptosporidium spp., and Entamoeba spp. These are more frequently the agents 
of diarrheal disease in developed countries. However, globally they are a less 
frequently determined cause of diarrheal disease [7].   
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  The symptoms of diarrhea include passage of three or more loose to 
watery stools per day and acute diarrhea can be categorized by its clinical 
presentation [8-10]. Acute diarrhea can last for a span of several hours to days, 
presenting with or without blood, the former is referred to as dysentery. The 
infected person can quickly become dehydrated from loss of body fluid and 
electrolytes and the dehydration can be worsened by fever and vomiting. 
Symptoms may vary according to the causative agent of the infection. 
Dehydration is considered the most severe result of diarrheal disease, as death can 
quickly follow if fluids and electrolytes are not replenished [11-14]. 
Causes and Preventative Measures  
By providing access to clean water and implementing simple 
improvements in waste management, occurrence and mortality rates of diarrheal 
diseases can be drastically reduced. Unfortunately, many of these diseases occur 
in developing countries that do not have the physical, economic, or educational 
resources to easily and rapidly install these capabilities [15-17]. Natural disasters 
and internal conflicts greatly worsen safe water availability and increase the risk 
of waterborne diseases, even in industrial and developing countries. In 2005, after 
Hurricane Katrina made landfall in New Orleans, Louisiana, the Centers for 
Disease Control (CDC) reported 22 new cases of Vibrio-related illness just two 
weeks after the hurricane. The CDC also strongly recommended any persons 
working in hurricane-damaged areas to wear extensive protective gear and avoid 
any  exposure to brackish water or seawater, whenever possible [18]. A major 
flooding event in Bangladesh in 2004 was associated with approximately 17,000 
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cases of cholera, ETEC, and other diarrheal diseases [19]. Two studies in 
Indonesia reported exposure to floodwaters was associated with a significant 
increase in the likelihood of exposure to, and infection by, Salmonella enterica 
serotype Paratyphi A (paratyphoid fever) and Cryptosporidium parvum [20].  
General conflict and war increase exposure of military personnel and 
civilians alike to infectious disease agents and, notably, limit access to clean 
water. American military personnel have reported several instances of diarrheal 
disease when serving in Iraq, Afghanistan, and Southeast Asia [21-23]. Refugee 
camps established for civilians fleeing conflicts are essentially incubators for 
infectious disease, as the refugees often have to tolerate poor, cramped living 
conditions without regular access to clean water, soap, and proper medical 
treatment [24-26]. As water becomes a scarce resource in these areas, aid workers 
become targets of criminal activity as they attempt to deliver food and clean water 
to civilians living in the war-torn areas. The international charity organization 
Médecins Sans Frontières (MSF) reported attacks on health facilities and aid 
workers in Afghanistan, the Central African Republic, South Sudan, the Syrian 
Arab Republic, and Yemen [27]. 
 Due to these and many related challenges, access to safe drinking water is 
always an issue that never is completely resolved. Therefore, it is imperative to 
monitor and characterize waterborne pathogens to achieve a better understanding 
of the mechanism of infection and epidemiology. 
The role of Aeromonas spp. in causing diarrheal disease has long been 
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debated, and the debate is still ongoing. [28]. Nevertheless, the available evidence 
suggests these bacteria pose a real threat to public health and safety [28, 29].  
Taxonomy of the Genus Aeromonas 
 The study of the Gram-negative, oxidase positive, rod-shaped organisms 
belonging to the genus Aeromonas has been hindered by debate and confusion for 




 century, Aeromonas species 
were identified as belonging to at least 15 other genera. Because of this confusion 
in the classification of Aeromonas spp. and debate over identification of 
Aeromonas as its own genus, it is difficult to determine the first instance of the 
laboratory isolation of any Aeromonas species [30]. 
The earliest likely reference to an Aeromonas bacterium was published in 
1890, when a then-novel species was isolated from drinking water supplies in the 
city of Chemnitz, Germany and characterized as Bacillus punctatus by 
Zimmerman [31]. Other early descriptions of potential Aeromonas species were 
published and named separately by Ernst and Sanarelli and correlated with a 
disease in frogs and subsequently other cold-blooded animals.  The genus 
Aeromonas was proposed in 1936 by Kluyver and van Niel, based on 
fermentative properties unique to Gram negative rods with polar flagella that had 
been described at the time [32].  
During the first few decades following establishment of Aeromonas as a 
genus, aeromonads could be roughly broken into two major groupings based upon 
their growth characteristics and results of DNA-DNA hybridization experiments. 
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The psychrophilic strains, containing isolates currently residing within the species 
Aeromonas salmonidica, were nonmotile and typically associated with fish 
diseases. The mesophilic group was more similar to Aeromonas hydrophila and 
was associated with a variety of human infections [29].  
The first laboratory isolation of Aeromonas  caviae was achieved in 1936 
by Liu, who isolated  it from septic guinea pigs  and initially named the isolate 
Pseudomonas caviae [33]. This isolate and subsequent isolates were later 
regrouped into a subspecies of Aeromonas  punctata and finally labelled as its 
own species by Popoff and Véron in 1976 [34]. 
The latest edition of Bergey’s Manual of Systemic Bacteriology recognizes 
a total of 14 species of Aeromonas, identified primarily based on DNA-DNA 
hybridization and 16S sequence analysis [35]. Recently, further multi-locus 
sequence typing (MLST), using multiple housekeeping genes, and results of 
advances in genome sequencing, this categorization has been expanded. Thus, as 
of 2017, there are currently a total of 36 species and 12 subspecies recognized in 
the list of prokaryotic names with standing in nomenclature 
(http://www.bacterio.net) and available from the Leibniz Institute DSMZ-German 
Collection of Microorganisms and Cell Cultures. 
Aeromonas as a Human Pathogen 
Because they possess to a broad range of extracellular enzymes, the 
aeromonads have long been associated with disease in both cold blooded animals 
and humans, causing multiple types of infections. The most recognized 
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mesophilic species commonly associated with some form of human infection are 
A. hydrophila, A. sobria, and A. caviae [29]. 
Actual virulence and disease caused by Aeromonas species depends on 
several variable factors and the disease process in Aeromonas is not completely 
understood in all areas of infection. However, Aeromonas species have been 
shown to possess genes enabling motility, adhesion, multiplication within a host, 
as well as potentially virulent enzymes secreted by Type II and Type III secretion 
systems, all of which can be considered requirements for a microorganism to be 
pathogenic [36].  
Clinical infections can be separated into two broad categories: intestinal 
and non-intestinal infections. Non-intestinal infections, commonly a result of 
exposure to polluted freshwater, include tissue infections and septicemia, and 
have been well documented in the literature [37-40]. Exposure to polluted water is 
especially likely to result in an infection in those who suffer severe physical 
trauma or who are immunocompromised at the time of exposure. Wound 
infections, sometimes accompanied by septicemia, often result in cellulitis, while 
cases of necrotizing fasciitis requiring limb amputation have also been reported 
[41]. Cases of septicemia without initial wound infection or in an 
immunocompromised patient have also been reported and the initial source(s) of 
infection have been  considered unclear [29]. 
Aeromonas as a Cause of Gastroenteritis 
The potential for aeromonads to colonize and cause gastroenteritis in 
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humans has previously been the subject of extensive debate, based on the 
perceived lack of true clonal outbreaks and  apparent non-fulfillment of Koch’s 
postulates since  several strains were isolated  and a low number of acute illnesses 
resulted  from the  single human challenge study that has been done [28]. Multiple 
studies have shown that Aeromonas strains  causing  diarrhea in patients were a 
identical to those  found in local drinking water and other food sources considered 
the  potential source of infection. A study by Khajanchi et al. (42) indicated 
conservation of genetically identical virulence factors and indistinguishable 
pulsed-field gel electrophoresis (PFGE) patterns between clinically and 
environmentally isolated strains of Aeromonas species. Results of the study 
presented here also show multiple patients from widely geographically distant 
regions of Haiti were shedding strains of Aeromonas that are presumed 
genetically identical as shown by multi-locus sequence typing (MLST). These 
results suggest that clonal outbreaks are indeed possible and may have already 
occurred.  
Koch’s postulates were anecdotally fulfilled by a gastrointestinal infection 
of A. trota when a laboratory worker accidentally ingested some of a liquid 
culture, as shown by Carnahan, et al. [42]. The results of the laboratory accident 
may be difficult to replicate in animal systems, due to evidence showing very 
stringent requirements for colonization and infection after ingestion of an 
Aeromonas species [28]. Researchers must consider the type  of strain, if more 
than one strain is present, the immune status of the patient, and the fact that 
multiple strains and species have been shown to play a role in contributing to the 
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virulence of Aeromonas [43].  
It is also possible that Aeromonas spp. play a role in polymicrobial 
infections, as they have been isolated from clinical fecal samples in conjunction 
with other pathogens. Historically, Aeromonas spp. have been co-isolated from 
diarrhea samples along with both bacterial and viral pathogens, such as Vibrio 
cholerae, Vibrio parahaemolyticus, E. coli, and Norwalk-like viruses [44-46]. 
Few reports have investigated this interaction or potential for co-infection, so 
future studies investigating the capability of Aeromonas spp. to function as an 
enteric pathogen should take this possibility into account. 
Animal models have also helped reinforce the hypothesis that Aeromonas 
spp. have the ability to colonize the human gut. Dos Santos et al. demonstrated 
the ability of five clinically isolated strains of A. caviae to successfully adhere to 
the colonic mucosa of the rabbit intestine, establishing a biofilm on its surface 
[47].  
The findings from all of these reports place the above-mentioned 
challenge study into question. Multiple strains were examined, but considering the 
multitude of factors required for infection and even shedding of virulent 
Aeromonas species, further studies using volunteer challenges are needed. Real 
world outbreaks have suggested that very specific cell concentrations or host 
conditions are required for infection to occur, which calls into question the ability 
for laboratory controlled challenge experiments to accurately mirror real world 
conditions. A model generated by Teunis and Figueras estimated the median dose 
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for a 1% risk of illness to be just 0.9 ingested colony-forming units (CFU), 
calculated from exposure events [28]. 
Intestinal Infections Caused by Aeromonas spp. 
 Aeromonas-associated diarrhea has been well-documented as a worldwide 
health issue and reported in both industrialized and developing nations. The 
patient population can vary, with Aeromonas gastroenteritis diagnosed in all age 
groups, although a greater risk of infection has been reported in children under the 
age of five, as well as in those considered immunocompromised [48]. A review of 
the literature by Holmberg and Farmer reported finding Aeromonas spp. were 
found in the stools of 0.04% to 21% of those diagnosed with gastrointestinal 
disease versus 0% to 10% of healthy controls [49]. These frequencies are 
relatively similar to isolation incidences of Salmonella, Shigella, and 
Campylobacter spp. in ill versus healthy persons, all of which are well known and 
characterized causes of enteric disease in humans [50].   
 Gastroenteritis caused by Aeromonas spp. can have an incubation period 
of 1 to 2 days [49]. Stools produced during Aeromonas gastroenteritis have been 
described as dysenteric and watery, sometimes accompanied by abdominal pain 
and vomiting. The most commonly reported symptoms associated with an 
Aeromonas infection are an inflammation of the large and small intestine, watery 
diarrhea, and abdominal pain. It is estimated that these symptoms account for 
approximately 75% to 89% of all cases of Aeromonas gastroenteritis [29]. One 
study noted a high frequency (60%) of vomiting in younger children suffering 
from Aeromonas gastroenteritis [49]. Another study in Hong Kong noted that a 
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person with Aeromonas gastroenteritis had an average of 8.6 loose or watery 
stools per day, with symptoms lasting for three days and accompanied by mild to 
moderate dehydration [51]. Much less common is Aeromonas gastroenteritis 
associated with mucus and blood in the stools. Previous studies have reported 
these symptoms present in 3% to 22% of cases [51-53].  
 On a few rare, documented occasions, Aeromonas gastroenteritis has 
presented with cholera-like symptoms, with multiple rice watery stools and 
vomiting, resulting in severe dehydration. Kumar and Kumar described such a 
case in a 2-year-old girl in India, who was hospitalized and able to recover within 
two days [54]. Champsaur et al. described another similar case of cholera-like 
symptoms with A. caviae being recorded as the sole isolated pathogen. In this 
case, a 67-year-old woman lost 13 liters of “rice-water” stools and recovered after 
seven days of hospitalization [55]. Other similar cases have been documented in 
Cuba and Libya [56, 57].  
Virulence Factors 
 Numerous strains of Aeromonas species that have been characterized or 
sequenced carry features that are assumed to be necessary for causing 
gastroenteritis in humans. However, the precise mechanisms of Aeromonas 
infections are not completely understood, so it is unclear which virulence factors 
are absolutely required for infection. Some studies have tried to correlate specific 
virulence factors with increased severity in symptoms, but no single factor or set 
of virulence genes has been consistently identified as a required indicator for the 
ability to cause or worsen gastroenteritis [29]. 
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 Polysaccharides produced on the exterior of the cell, such as capsules, S-
layers, and extracellular polysaccharides have all been well characterized and 
documented, and are important in attachment and colonization of a host organism 
[47]. Biofilms formed by the excretion of polysaccharides aid in establishing an 
anchored community within the host and the bacteria can then avoid attacks by a 
local immune system [58]. Lipoplysaccharaides in the cell envelope have also 
been well characterized in some Aeromonas spp. and are often correlated with 
high immunostimulatory activity that can present a wide range of clinical 
manifestations in both septicemia and tissue infections [59-61].  
 Proteases are a well-studied class of enzymes that catalyze the cleavage of 
peptide bonds and contribute to invasion of the pathogen within the host by 
causing direct damage to host tissue and the initial immune defense [62]. 
Laishram and Pennathur were able to purify an alkaline thermostable 
metalloprotease from a strain of A. caviae [63]. Cascón et al. were  able to 
demonstrate a specific protease (ahyB)  essential for pathogenicity of A. 
hydrophila in fish and required to maintain  proteolytic activity.   The sequence of 
this protein shares 61% and 53% identity with metalloproteases of organisms 
capable of causing disease, namely Helicobater pylori and V. cholerae, 
respectively, suggesting similar capability as a pathogenicity factor [64].  
 Another extracellular class of virulence factor produced by Aeromonas 
spp. includes the pore-forming toxins, aerolysin and hemolysin. These enzymes 
cause osmotic lysis and destruction of erythrocytes in the human immune system 
[62]. A study by Wong, et al. [65] demonstrated that the aerolysin and hemolysin 
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profile of Aeromonas is significantly correlated with cell culture cytotoxicity, 
suggesting these enzymes, or specific combinations of these enzymes, play an 
important role in human pathogenesis. These genes also show similarity to the 
aerolysin and hemolysin in V. cholerae, where they also contribute to enhanced 
virulence. 
 Both cytotoxic and cytotonic extracellular toxins have been characterized 
in Aeromonas spp. [36, 66]. The cytotoxic enterotoxin encoded by the gene act is 
an aerolysin-related pore-forming toxin capable of provoking degeneration of 
crypts and villi of the small intestine, and is typically found in isolates recovered 
from the stool of patients suffering diarrhea [67, 68]. It is considered responsible 
for hemolytic, cytotoxic, and enterotoxic activities of A. hydrophila, and 
considered by some to be one of the main virulence factors.  
 Cytotonic enterotoxins do not result in the degeneration of the epithelium, 
but are more closely similar in action to the cyclic adenosine monophosphate 
(cAMP) and prostaglandin-mediated mechanism of cholera toxin in intestinal 
epithelial cells. These toxins increase the production of cAMP and prostaglandins 
resulting in the forced export of massive amounts of nutrients from epithelial 
cells, making them readily available to enteric pathogens and causing diarrhea in 
an infected patient. These are divided into heat-labile (alt) and heat-stable (ast) 
sub-categories [69, 70].  
 In general, Aeromonas spp. secrete a wide range of extracellular enzymes, 
such as lipases, amylases, chitinase, nucleases, and gelatinases. It is unknown 
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what exact roles these play in pathogenicity, but they demonstrate the potential to 
readily adapt to environmental changes and contribute to a large metabolic 
diversity which could aid in survival during host infection [36]. A few lipases 
have been previously described and have been linked to a significant increase in 
both hemolytic and cytotoxic activity and overall pathogenicity in both fish and 
mice [71, 72]. 
 Type III and VI secretion systems (T3SS and T6SS) have been 
documented as playing a critical role in the virulence of Gram-negative 
pathogens, acting as transport mechanisms for toxins and other protein products 
across the outer membrane into host cytoplasm. The T3SS contains an 
injectisome, consisting of about 20 proteins that assemble into a needle-like 
structure anchored to the envelope, capable of translocating proteins into the 
cytosol of the host cells. Functioning T3SS have been described in both A. 
salmonicida and A. hydrophila [73-76]. A T6SS works similarly, with a phage-
tail-spike-like injectisome, again capable of translocating toxins into a host cell. 
Only a few characterized strains of A. hydrophila contain functional T6SS and 
have been linked to some involvement in virulence [77, 78].  
 Finally, the ability of locomotion, using flagella, is a key factor in 
colonization and invasion of the host mucosa. Within the gut, motility and 
chemotaxis are required for the pathogen to reach the target tissue. The lateral and 
polar flagella of Aeromonas spp. are also capable of acting as adhesions, aiding in 
attachment to host cells. Lateral flagella additionally have a required role in 
biofilm formation, another key factor in pathogenicity [79-81]. 
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 Because of the rather unclear status of Aeromonas as an enteric pathogen 
and the still yet to be defined mechanism of infection, it is important to monitor 
clinical strains for all of the above virulence factors, with the expectation  that a 
defining  pattern will emerge that will allow  for a better understanding of 
aeromonads as pathogens.  
Aeromonas in the Environment 
 Aeromonads are essentially ubiquitous in the microbial biosphere and 
have been isolated from diverse ecological niches, frequently found as part of the 
flora of vertebrates and invertebrates, as well as in soil and both fresh and salt 
water. Aeromonas species have been previously isolated from a broad range of 
organisms, spanning several different phyla [29]. Several Aeromonas species 
containing genes encoding virulence factors have been isolated from the surface 
and intestinal tract of both tilapia fish (Tilapia nilotica) and catfish (Clarias 
betrachus), the feces of the primate long-tailed macaque (Macaca fascicularis), 
houseflies (Musca domestica), and the hepatopancreas of a giant freshwater 
prawn (Macrobrachium rosenbergii) [82-84]. 
 A study by Hazen et al. [85] identified viable A. hydrophila in 135 of 147 
(91.8%) natural aquatic habitats sampled in the United States and Puerto Rico. 
Aeromonas spp. have been repeatedly isolated from rivers, lakes, ponds, estuaries, 
drinking water, groundwater, wastewater, and sewage, with concentrations 
varying from lows of <1 CFU/ml to highs of 10
8
 CFU/ml [29]. The abundance of 
Aeromonas reservoirs provide ample opportunities for exposure and increased 




Notably, the clinically relevant species, A. hydrophila, A. caviae, and A. 
veronii bv. sobria, considered responsible for a large majority of human infections 
are those Aeromonas spp.  most frequently isolated from environmental water 
sources and food [29]. Since they belong to the mesophilic group of Aeromonas 
spp., rates of their isolation and reported infections of the gastrointestinal tract are 
affected by seasonality and local climate. Most studies have found that they are 
more commonly isolated during the warmer months of the year or from  




Chapter 2  Aeromonas spp. Isolated from Patients During the Cholera 
Outbreak in Haiti in 2010 
 
Introduction 
 Members of the genus Aeromonas,  Gram-negative, rod-shaped, 
facultative aerobes,  are gaining  recognition as an emerging enteric opportunistic 
or primary pathogen [28]. They are considered ubiquitous in the environment, 
having repeatedly been isolated from both fresh and salt water, soil, and from 
both vertebrate and invertebrate animals. Due to their ubiquity in the 
environment, the potential for human exposure is nearly constant. Human 
infections caused by Aeromonas species include soft tissue and wound infections, 
bacteremia, and gastroenteritis [29]. The current edition of Bergey’s Manual of 
Determinative Biology recognizes 14 species of Aeromonas, but only three of 
them, A. caviae, A. hydrophila, and A. veronii biovar sobria have been associated 
with gastrointestinal disease [35].  
Though the specific role of Aeromonas in gastroenteritis is still being 
debated, many putative virulence factors that appear to contribute to 
gastroenteritis have been identified. Several functioning cytotoxin, enterotoxins, 
hemolysins, and secretory systems have been well characterized in several strains 
of all clinically relevant Aeromonas spp. [36]. Some environmental and clinical 
strains of A. caviae that have been isolated were found to carry genes encoding a 
Shiga toxin similar to that coded by stx1, the Shiga toxin gene found in 
Escherichia coli O157:H7, and other strains of Shiga toxin-producing E. coli 
(STEC) [90, 91]. A. caviae has also demonstrated the ability to adhere to and 
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colonize the colonic mucosa of rabbit intestine [47]. However, attempts to fulfill 
Koch’s postulates with other animal models during a human volunteer study  
challenged the hypothesis  that  Aeromonas spp. are a  direct causative agent of 
gastroenteritis [92]. It is possible that numerous factors must be considered when 
determining the enteropathogenicity of Aeromonas species, such as the immune 
status of the patient, the specific species and strains involved, the discrepancy in 
expression of virulence factors in different environmental conditions, and the 
possible involvement and collaboration of other pathogens present in the intestinal 
tract [29]. Aeromonas spp. have been isolated along with other enteric pathogens 
such as Norwalk-like viruses, Vibrio cholerae, and enterotoxogenic E. coli 
(ETEC) [44-46]. Yet Aeromonas spp. remain important, if still ill-defined, players 
in gastrointestinal infection. Therefore, it is necessary to identify and characterize 
putative virulence factors in each clinical isolate of Aeromonas spp. shed from 
persons suffering symptoms of gastrointestinal infection. 
 On January 12, 2010, a 7.0 magnitude earthquake struck Haiti, t 25 
kilometers southwest of the Haitian capital of Port-au-Prince, with the epicenter 
located underneath the city of Léogâne [93]. Three more aftershocks were 
recorded, two registering at magnitude 5.9 and a third at 5.5. Much of the country 
was already dealing with inadequate infrastructure, including lack of access to 
clean drinking water and only substandard medical facilities being available to a 
large portion of the population. Additionally, due to a lack of adequate 
reinforcement structure of many buildings, much of the capital and surrounding 
area lay in ruins. It is estimated that three million people were affected by the 
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earthquake, making up nearly one third of the entire  population of the country 
[94]. With extensive damage done to already poor sewage and drinking water 
facilities, the potential for a waterborne outbreak of any kind was very high [95]. 
 The first cases of Haitian patients exhibiting symptoms of vomiting and 




 of 2010 in Bocozel 
and Deschapelles, towns located in the Artibonite Department, both located along 
the Artibonite River. Specimens collected from these cases were sent to the 
Laboratorie National de Santé Publique (LNSP) in Port-au-Prince for diagnosis. 
On January 21, 2010, eight of these samples tested positive for Vibrio cholerae 
O1 and, therefore, were the first confirmed cases of cholera in Haiti since 1960. 
However, a later study showed V. cholerae to be present in Haiti as early as 2008 
[96] . V. cholerae was  isolated from acute diarrhea victims throughout the 
country within a month and cholera was confirmed in all ten departments of Haiti 
[95, 97]. 
 This study was designed to determine if Aeromonas spp. had any role in 
the outbreak by examining clinical fecal samples collected from 81 Haitian 
patients suffering symptoms of gastroenteritis within the first three weeks of the 
2010 Haitian cholera outbreak. Biochemical analysis, followed by polymerase 
chain reaction (PCR) amplification of an Aeromonas-specific 16S sequence was 
used for initial identification to genus. Multi-locus sequence typing (MLST) was 
employed for species identification of all strains. Isolates of A. caviae were 
characterized using biochemical analysis, including virulence traits, antimicrobial 




Sample Collection and Bacterial Isolation 
  
          During a three-week period, early in the 2010 Haitian cholera outbreak, a 
fecal sample was collected from each of 81 individuals experiencing symptoms of 
gastroenteritis or typical “cholera-like” symptoms, normally rice-water diarrhea, 
vomiting, and abdominal pain. Samples were collected at the Nuestros Pequeños 
Hermanos (NPH) Haiti Saint Damien Pediatric Hospital in Tabarre, Haiti, at rural 
mobile health clinics near the city of Saint-Marc, or at the individual’s residence. 
In total, the samples included at least one individual from each of 18 towns across 







 Figure 1.  Source and distribution of clinical sampling locations. All samples 
were collected in November 2010, during the first weeks of the 2010 Haitian 
cholera outbreak. Green markers indicate sites where A. caviae was isolated from 
at least one clinical sample.   
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The 81 fecal samples were streaked onto thiosulfate-citrate-bile-salts 
sucrose (TCBS) agar and grown overnight at ambient room temperature. All 
colonies on TCBS agar were transferred and cultured in Luria-Burtani (LB) agar 
stabs in 1.5 mL microcentrifuge tubes, and sealed with parafilm for transport. 
After a three-day transport at ambient conditions, the LB agar was removed and 
cut in half. Half was used to streak directly onto TCBS agar, and the other half 
was incubated in 50 ml of alkaline phosphate water (APW) for eight hours at 
37˚C. After incubation for eight hours, the top of the broth was skimmed and 
streaked onto TCBS for overnight incubation at 37˚C. Colonies displaying unique 
morphologies were picked, in duplicate, if identical colonies had formed. Stock 
cultures were maintained at -80°C in LB broth containing glycerol at 25% (v/v).  
For bacterial DNA extraction, each isolate was grown in 5 mL LB broth at 
37°C. After overnight growth 1 ml of broth culture was centrifuged for 10 
minutes at 8000xg. Bacterial DNA was extracted using the Qiagen DNA Mini Kit 
according to the manufacturer’s instructions. DNA was stored in nuclease free 
water at -20°C. 
PCR Reactions 
Genomic DNA extracted from yellow, sucrose fermenting colonies on 
TCBS was subjected to PCR, employing gene probes for V. cholerae 
transmembrane regulatory protein (toxR) and outer membrane protein (ompW) 
[98, 99]. Isolates positive for these genes were identified as V. cholerae and 
further categorized as O1, O139, or non-O1/O139 using the Hoshino multiplex 
assay. A primer previously developed for the 16S region in Aeromonas spp. was 
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used for identification of isolates as Aeromonas. The 16S rRNA gene of all non-
V. cholerae was sequenced and genus level identification performed using the 
online search BLAST tool.  
 Species identification and genomic diversity of the putitative Aeromonas 
isolates were determined using multi-locus sequence typing (MLST) of six 
housekeeping genes: DNA gyrase subunits A and B (gyrA, gyrB); RNA 
polymerase sigma factor 70 (rpoD); DNA polymerase subunits gamma and tau 
(dnaX); a DNA chaperone (dnaJ); and ATP synthase F1 beta subunit (atpD). 
Primers were used as previously described (Table 1) [100]. The resulting 
sequences were concatenated and aligned with sequences from 25 other 
Aeromonas species. Phylogenetic analyses were conducted using the MEGA7 
program [101].  
Virulence capabilities of confirmed strains of Aeromonas caviae were 
presumptively characterized by presence of genes encoding known virulence 
factors. Primers used in this PCR analysis targeted genes for various proteases, 
hemolysins, and exotoxins as previously described. Genes encoding effector 
proteins of type III secretion systems (T3SS) and type VI secretion systems 
(T6SS) were targeted (Table 1).   
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Table 1. Primers used in this study targeting housekeeping genes for MLST 
analysis (gyrB, rpoD, gyrA, dnaJ, dnaX, atpD), and for putative virulence factors 



































F1 sector of membrane-bound 





ela-F CGGGTGCACTACAGCCGCAA This 
study ela-R CGGGCCGGGTCCTCGAAGTA 
AChly Aeromonas caviae hemolysin 
AChly-F CTGGCTGATCCGCGGCAACA This 





















flaA Polar flagella 
flaA-F CAACCGCAACGCCAACGACG This 
study flaA-R CGCGCGGCACTGACGTTTTC 















 Two layers of a milk agar plate were prepared individually by separately 
autoclaving 2% (w/v) non-fat dry milk (Nestle) solution and 1.5% agar solution. 
When preparing plates, the solutions were cooled and mixed prior to pouring to 
approximately half the volume of the dish. After the agar had solidifyied, an 
overlay of Marine Agar 2216 (Difco) was added to form an upper nutrient layer. 
10 L of overnight broth culture of each strain in LB broth was spotted onto the 
surface of the medium and incubated overnight at 37˚C. Visible areas of clearing 
in the lower milk layer surrounding each cluster of growth was considered an 
indication of positive proteolytic activity [101]. 
 A modified Congo red agar assay was used to detect biofilm production, 
as previously described by Hassan et al. The Congo Red Agar (CRA) medium 
was prepared with brain heart infusion broth (Oxoid) 37 g/L, sucrose 50 g/L, and 
10 g/L agar. The Congo red indicator was separately prepared in an 8 g/L solution 
and mixed with the other components of the medium after sterilization. Plates 
were inoculated with each isolate and incubated overnight at 37˚C. Black colonies 
with a dry crystalline consistency indicated biofilm production [108]. 
 Hemolytic activity was determined by growth on Tryptic Soy Agar with 
5% sheep blood (Hardy Diagnostics). Areas of agar around the colonies that were 
transparent and yellow were recorded as beta-hemolysis. Green discoloration of 




Antimicrobial susceptibility  
  
             The disc diffusion method was used to investigate antibiotic susceptibility 
of all strains to a range of antibiotic classes, most which have been previously 
cited as an effective treatment against Aeromonas infections [109-112]. Single 
colonies of overnight cultures on LB agar were picked, suspended in 3.0 mL 
sterile saline, and diluted to obtain turbidity of 0.5 McFarland turbidity standard. 
Sterile swabs were used to inoculate Mueller-Hinton agar and antibiotic discs 
were applied to the surface of the agar. After incubating overnight at 37˚C, the 
diameter of the zone of inhibition was measured and compared to the 
manufacturer’s standards. 
Results 
 From the 81 fecal samples, a total of 161 unique colony morphologies 
were identified on TCBS, an average of two unique morphologies per stool 
sample. Each morphology type was picked in duplicate, yielding 310 total 
isolates. MLST analysis identified Aeromonas spp. in 17 (21%) of the fecal 
samples, and V. cholerae O1 and V. cholerae non-O1/O139 were identified in 39 
(48%) and 17 (21%) of the samples. Both V. cholerae and Aeromonas spp. were 
isolated from the same fecal sample in seven cases, while no other pathogen was 
identified in the remaining ten. Ten of the 310 cultures could not be recovered 
after glycerol storage. The remaining isolates identified by 16S rRNA sequencing 
were found to belong to the genera Enterococcus, Proteus, and Citrobacter (Table 
2).   
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Table 2. List of samples, strain ID, patient corresponding isolation sites, and 
species (NG – no growth, unable to recover after transport) 
Patient Isolate Sample  Species Patient Town Arrondissement Department 
1 A 1 V. cholerae Saint-Marc Saint-Marc Artibonite  
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
2 A 1 V. cholerae Saint-Marc Saint-Marc Artibonite  
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
   
 
B 2 P. mirabilis 
     C 1 V. cholerae       
3 A 1 A. caviae Saint-Marc Saint-Marc Artibonite  
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
4 A 1 E. faecalis Gonaïves Gonaïves  Artibonite  
5 A 1 P. mirabilis Saint-Marc Saint-Marc Artibonite  
 
A 2 P. mirabilis 
     B 1 NG       
6 A 1 V. cholerae Saint-Marc Saint-Marc Artibonite  
 
A 2 V. cholerae 
   
 
B 1 A. caviae 
     B 2 A. caviae       
7 A 1 V. cholerae Grande Saline Dessalines Artibonite  
  A 2 V. cholerae       
10 A 1 P. mirabilis Saint-Marc Saint-Marc Artibonite  
  A 2 P. mirabilis       
11 A 1 P. mirabilis Gonaïves Gonaïves  Artibonite  
  A 2 P. mirabilis       
12 A 1 P. mirabilis Drouin Saint-Marc Artibonite  
 
A 2 P. mirabilis 
     B 1 E. cloacae       
13 A 1 P. mirabilis Saint-Marc Saint-Marc Artibonite  
 
A 2 P. mirabilis 
   
 
B 1 E. faecalis 
     B 2 E. faecalis       
14 A 1 A. caviae Chansolmes Port-de-Paix Nord-Ouest 
 
A 2 A. caviae 
   
 
B 1 P. mirabilis 
   
 
C 1 E. gilvus 
   
 
D 1 P. mirabilis 
     E 1 E. faecium       
15 A 1 P. mirabilis Saint-Marc Saint-Marc Artibonite  
  A 2 P. mirabilis       
16 A 1 P. mirabilis Grande Saline Dessalines Artibonite  
  A 2 P. mirabilis       




A 2 V. cholerae 
   
 
B 1 A. caviae 
   
 
B 2 A. caviae 
     C 1 V. cholerae       
18 A 1 P. mirabilis Saint-Marc Saint-Marc Artibonite  
 
A 2 P. mirabilis 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
19 A 1 V. cholerae Saint-Marc Saint-Marc Artibonite  
 
A 2 V. cholerae 
   
 
B 1 A. caviae 
   
 
B 2 A. caviae 
   
 
C 1 P. mirabilis 
     C 3 P. mirabilis       
20 A 1 V. cholerae Saint-Marc Saint-Marc Artibonite  
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
21 A 1 V. cholerae Saint-Marc Saint-Marc Artibonite  
 
A 2 V. cholerae 
     B 1 P. mirabilis       
22 A 1 V. cholerae Saint-Marc Saint-Marc Artibonite  
 
A 2 V. cholerae 
   
 
B 1 A. caviae 
   
 
B 2 A. caviae 
   
 
C 1 P. mirabilis 
     C 2 P. mirabilis       
23 A 1 V. cholerae Bassin Bleu Port-de-Paix Nord-Ouest 
 
A 2 V. cholerae 
   
 
B 1 A. caviae 
   
 
B 2 A. caviae 
   
 
C 1 P. mirabilis 
     C 2 P. mirabilis       
25 A 1 A. caviae Saint-Marc Saint-Marc Artibonite  
 
A 2 A. caviae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
26 A 1 A. caviae Saint-Marc Saint-Marc Artibonite  
 
A 2 A. caviae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       






  A 2 P. mirabilis       
28 A 1 V. cholerae En Plein Gonaïves Ouest 
 
A 2 V. cholerae 
   
 
B 1 A. caviae 
   
 
B 2 A. caviae 
   
 
C 1 P. mirabilis 
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  C 2 P. mirabilis       
29 A 1 P. mirabilis Tabarre Port-au-Prince Ouest 
  A 2 P. mirabilis       
30 A 1 P. mirabilis Port-au-Prince Port-au-Prince Ouest 
 
A 2 P. mirabilis 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
31 A 1 P. mirabilis Delmas Port-au-Prince Ouest 
 
A 2 Enterococus 
   
 
B 1 NG 
     B 2 P. mirabilis       
32 A 1 V. cholerae Cite Soleil Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
33 A 1 NG Tabarre Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
   
 
B 2 P. mirabilis 
   
 
C 1 NG 
     C 2 P. mirabilis       
34 A 1 P. mirabilis Petion Ville Port-au-Prince Ouest 
 




B 1 P. mirabilis 
 
  
  C 1 C. braakii       







A 2 P. mirabilis 
   
 
B 1 E. faecalis 
     B 2 E. faecalis       
36 A 1 V. cholerae Tabarre Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
37 A 1 V. cholerae En Plein Gonaïves Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       







A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
39 A 1 V. cholerae Port-au-Prince Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
40 A 1 V. cholerae Arcahaie Arcahaie Ouest 
 
A 2 V. cholerae 




B 1 P. mirabilis 
     B 2 P. mirabilis       
41 A 1 V. cholerae 
   
 
A 2 V. cholerae 
   
 
B 1 V. cholerae 
     B 2 V. cholerae       
42 A 1 V. cholerae Cite Soleil Port-au-Prince Ouest 
  A 2 V. cholerae       
43 A 1 V. cholerae Delmas Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 V. cholerae 
     B 2 V. cholerae       







A 2 V. cholerae 
   
 
B 1 E. faecalis 
   
 
B 2 E. faecalis 
   
 
C 1 P. mirabilis 
     C 2 P. mirabilis       







A 2 V. cholerae 
   
 
B 1 E. faecalis 
   
 
B 2 E. faecalis 
   
 
C 1 P. mirabilis 
     C 2 P. mirabilis       
46 A 1 V. cholerae Port-au-Prince Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 V. cholerae 
   
 
B 2 V. cholerae 
   
 
C 1 P. mirabilis 
     C 2 P. mirabilis       
47 A 1 V. cholerae Tabarre Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
48 A 1 V. cholerae Tabarre Port-au-Prince Ouest 
 
A 2 P. mirabilis 
   
 
B 1 P. mirabilis 
   
 
B 2 V. cholerae 
   
 
C 1 P. mirabilis 
     C 2 P. mirabilis       
49 A 1 V. cholerae Port-au-Prince Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 Enterococcus 
     B 2 Enterococcus       
50 A 1 V. cholerae Port-au-Prince Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
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  B 2 P. mirabilis       
51 A 1 V. cholerae Port-au-Prince Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
52 A 1 V. cholerae Port-au-Prince Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
53 A 1 A. caviae Cabaret  Arcahaie Ouest 
 
A 2 A. caviae 
   
 
B 1 NG 
   
 
B 2 P. mirabilis 
   
 
C 1 E. faecium 
   
 
D 1 E. faecalis 
     E 1 P. mirabilis       
54 A 1 A. caviae Cite Soleil Port-au-Prince Ouest 
 
A 2 A. caviae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
55 A 1 V. cholerae Delmas Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 Enterococcus 
   
 
B 2 V. cholerae   
  
 
C 1 Enterococcus 
     C 2 V. cholerae       







A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
57 A 1 V. cholerae Tabarre Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
58 A 1 A. caviae Petionville Port-au-Prince Ouest 
 
A 2 A. caviae 
   
 
B 1 NG 
   
 
B 2 NG 
   
 
C 1 P. mirabilis 
  
  
  C 2 P. mirabilis       
59 A 1 V. cholerae Port-au-Prince Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 V. cholerae 
   
 
B 2 P. mirabilis 
   
 
C 1 P. mirabilis 
     C 2 P. mirabilis       
60 A 1 V. cholerae Port-au-Prince Port-au-Prince Ouest 
 
A 2 V. cholerae 




B 1 Enterococcus 
     B 2 Enterococcus       







A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
62 A 1 V. cholerae Delmas Port-au-Prince Ouest 
 
A 2 P. mirabilis 
   
 
B 1 V. cholerae 
     B 2 P. mirabilis       
63 A 1 V. cholerae Cite Soleil Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
64 A 1 V. cholerae Port-au-Prince Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
   
 
B 2 P. mirabilis 
   
 
C 1 Enterococcus 
     C 2 Enterococcus       
65 A 1 V. cholerae Tabarre Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 A. caviae 
     B 2 A. caviae       
67 A 1 V. cholerae Port-au-Prince Port-au-Prince Ouest 
  A 2 V. cholerae       
68 A 1 V. cholerae Port-au-Prince Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
69 A 1 V. cholerae Cite Soleil Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       




A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
71 A 1 V. cholerae Port-au-Prince Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
72 A 1 V. cholerae Arcahaie Arcahaie Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
73 A 1 A. caviae Léogâne Léogâne Ouest 




74 A 1 A. caviae Cite Soleil Port-au-Prince Ouest 
  A 2 A. caviae       
75 A 1 A. caviae Tabarre Port-au-Prince Ouest 
  A 2 A. caviae       
76 A 1 NG Port-au-Prince Port-au-Prince Ouest 
 
A 2 NG 
   
 
B 1 NG 
     B 2 NG       
77 A 1 V. cholerae Plaine Gonaïves Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       







A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
79 A 1 V. cholerae Arcahaie Arcahaie Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
80 A 1 V. cholerae Cite Soleil Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 
     B 2 P. mirabilis       
81 A 1 V. cholerae Cite Soleil Port-au-Prince Ouest 
 
A 2 V. cholerae 
   
 
B 1 P. mirabilis 




 Alignment of sequences of the concatenated rpoD-gyrB-atpD-dnaJ-dnaX-
gyrA genes of the Aeromonas isolates showed highest nucleotide sequence 
similarity to Aeromonas caviae (Fig. 2a, 2b, 3). Neighbor-joining phylogenetic 
trees indicated the isolates to be largely non-clonal, clustering closely with strains 
A. cavaie CECT838 (ATCC 15468), originally isolated from Guinea pigs, and A. 
caviae MDC51, and A. caviae MDC52, both originally isolated from snails [100]. 
MLST analysis revealed three distinct evolutionary groups and a fourth outlier, 
isolate 6B-1. None of these clustered groups were isolated from stool samples 




Figure 2a Phylogenetic tree of Aeromonas spp. based on five housekeeping 
genes. Evolutionary history inferred using the Neighbor-Joining method [113]. 
Percentage of replicate trees in which the associated taxa clustered together in the 
bootstrap test (1000 replicates) are shown next to each branch [114]. Evolutionary 
distances were computed using the Maximum Composite Likelihood method 
[115]. The analysis involved 125 nucleotide sequences at a total of 3666 
positions. Analysis conducted using MEGA7 [101].  
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Figure 2b Additional phylogenetic tree of Aeromonas species based on five 
housekeeping genes.  
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Figure 3 Phylogenetic tree based on MLST analysis ofA. caviae and the Haitian 
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 Three strains from a single phylogenetic outgroup of the MLST analysis 
demonstrated a unique colony morphology when grown on LB agar, that was 
suggestive of abundant biofilm production. After incubation for 24 hours, no 
hemolytic activity was observed on blood agar. However, after incubation for 48 
hours at room temperature, the centers of growth of strains became yellow and 
transparent, indicative of beta-hemolysis. All strains produced clearing zones on 
skim milk plates, indicative of protease activity, and were confirmed to produce 
biofilm based on results of the Congo Red Agar assay.  
 Five putative virulence-related genes were detected in all 17 isolates: an 
elastase extracellular metalloprotease (ahyB); lipase (pla); flagella A (flaA); serine 
protease (asp); and T3SS effector protein (aexU). Four strains (24%) carried a 
gene for a hemolysin previously identified in other strains of A. caviae (AChlyA) 
and 13 (76%) possessed known genes coding for lateral flagella (lafA). The other 
virulence determinants were not detected.  
 Interestingly, 14 strains (82%) showed either resistance or intermediate 
resistance to ampicillin in the disc diffusion assay. All were resistant or showed 
intermediate resistance to trimethoprim/sulfamethoxazole, erythromycin, and 
tetracycline. Eight strains (47%) were resistant or, showed intermediate resistance 
to streptomycin, and another set of eight strains were resistant to kanamycin. All 




Table 3 Antimicrobial resistance pattern for each strain based on disc diffusion assay. Each is indicated as susceptible (S), 




Resistance (R), Intermediate Resistance (I), or Susceptibility (S) of Strains 
Ampicillin Ciprofloxacin Chloramphenicol 
Trimethoprim/ 
Sulfamethoxazole 
Streptomycin Tetracycline Aztreonam Kanamycin Imipenem 
3A-1 R S S R I R S S S 
6B-1 R S S R R R S S S 
14A-1 R S S R R R S S S 
17B-1 S S S R S R S R S 
19B-1 R S S R S R S R S 
22B-1 S S S R S R S R S 
23B-1 R S S R S R S R S 
25A-1 R S S R S R S R S 
26A-1 R S S R S R S R S 
52B-2 S S S R I R S R S 
54A-1 R S S R I R S S S 
58A-1 I S S R I R S R S 
65B-1 R S S R I R S S S 
73A-1 R S S R I R S S S 
74A-1 R S S R S R S S S 
75A-1 R S S R S R S S S 
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Table 4 Profiles of putative virulence genes present in each isolate as determined by PCR analysis. 
 
Strain  


































3A-1 + + + - - + + + - - + - 
6B-1 + + + - - + - + - - + - 
14A-1 + - + - - + + + - - + - 
17B-1 + - + - - + + + - - + - 
19B-1 + - + - - + + + - - + - 
22B-1 + - + - - + + + - - + - 
23B-1 + - + - - + + + - - + - 
25A-1 + - + - - + + + - - + - 
26A-1 + - + - - + + + - - + - 
52B-2 + - + - - + + + - - + - 
54A-1 + + + - - + + + - - + - 
58A-1 + - + - - + + + - - + - 
65B-1 + - + - - + + + - - + - 
73A-1 + + + - - + + + - - + - 
74A-1 + - + - - + - + - - + - 






 In this study, 21% of the fecal samples collected in Haiti in November, 
2010, were positive for A. caviae, similar to previously established isolation rates 
from patients suffering gastroenteritis [49]. The exact role of A. caviae during the 
early weeks of the 2010 Haitian cholera outbreak remains unclear since the 
conclusion was rapidly made that all cases presenting to the hospitals were 
cholera victims. All A. caviae strains exhibited virulence potential when tested 
using skim milk agar, blood agar and were found to carry genes encoding 
potential virulence factors. However, because the exact mechanism of 
pathogenicity of Aeromonas-associated gastroenteritis is not yet fully known, and 
no single virulence factor or set of virulence factors have been directly linked 
with illness caused by Aeromonas spp., it is difficult to  define these factors as the 
cause of the symptoms of enteric disease of each individual from whom the 
samples had been collected.  
 Unfortunately, detailed records or repeat samples from each patient could 
not be obtained due to the turbulent social, political, and physical environment of 
the first few weeks of the devastating disease outbreak. Sample collection often 
was done at  patient homes by a  physician working alone, with priority clearly 
and appropriately placed on rapid treatment, rather than sample collection, filling 
out questionnaires, or consideration of further data collection long-term.  
Many studies have hypothesized that Aeromonas spp. may interact 
synergistically with other pathogens to cause diarrhea [44-46]. Severity, duration, 
and symptoms of each individual providing a sample would have provided insight 
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into this possibility, particularly for those cases where V. cholerae was the only 
pathogen isolated, compared to cases where both V. cholerae and A. caviae were 
isolated. 
However, studies monitoring incidence of Aeromonas spp. in clinical fecal 
samples are important in deciding whether to accept or reject the hypothesis that 
Aeromonas spp. cause gastroenteritis in humans. A few previous studies 
established clonal outbreaks of Aeromonas infection, with a single genetically 
similar Aeromonas spp. isolated from both clinical fecal samples and the 
environment. Here, we report three groups of genetically identical clinical isolates 
collected essentially simultaneously from several distant geographic regions of 
Haiti. For example, isolate 23B-1 from Bassin-Bleu, is located in the same MLST 
group as 54A-1, from a sample collected in Cité Soleil, 142 kilometers away. 
These data suggest one or more clonal strains of A. caviae were endemic in Haiti 
during late 2010. 
Symptoms of Aeromonas-related gastroenteritis that have been reported in 
earlier studies have varied widely, ranging from moderate acute diarrhea to 
“cholera-like” symptoms [29, 55, 57]. Thus, clinical diagnoses, based on 
symptoms alone, as is often done in rapid treatment during major outbreaks, may 
not be reliable in identifying the etiological agent. Particularly in resource-limited 
areas such as Haiti, diagnosis is performed based on symptoms alone, out of 
necessity, to provide rapid treatment and the infrastructure for laboratory 
identification of the clinical isolates often is not available in that developing 
country. Both Aeromonas spp. and Vibrio cholerae are ubiquitous in the 
42 
 
environment, have similar routes of person to person transmission, and often have 
been reported to cause identical symptoms [54-57]. It may be difficult to fully 
understand the exact role A. caviae played in the initial onset of the Haitian 
cholera epidemic, but these results clearly indicate the importance of monitoring 
for Aeromonas spp. in major outbreaks of enteric disease. It is concluded from the 
results of this study that there is a clear need to investigate further the role played 
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